Distribution of COPD patients in the GOLD assessment framework by exacerbations

G. Nadeau, L. Adamek, M. Small (Uxbridge, Macclesfield, United Kingdom)

Source: Annual Congress 2012 - COPD epidemiology
Session: COPD epidemiology
Session type: Thematic Poster Session
Number: 980
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
G. Nadeau, L. Adamek, M. Small (Uxbridge, Macclesfield, United Kingdom). Distribution of COPD patients in the GOLD assessment framework by exacerbations. Eur Respir J 2012; 40: Suppl. 56, 980

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Validation of the GOLD 2017 classification in predicting exacerbations and mortality in COPD patients
Source: International Congress 2017 – What is new in COPD management and prognosis: findings from large studies?
Year: 2017

Prediction models for exacerbations in patients with COPD
Source: Eur Respir Rev 2017; 26: 160061
Year: 2017



Evaluation of the GOLD 2011 severity criteria across the COPD spectrum
Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations
Year: 2013

Distribution of a COPD population based on the GOLD assessment framework
Source: Annual Congress 2012 - Prevalences and characterstics of obstructive airway disease
Year: 2012


An evaluation of exacerbations in COPD
Source: Eur Respir J 2004; 24: Suppl. 48, 89s
Year: 2004

Agreement of severity stages and exacerbations building the new COPD risk groups
Source: Annual Congress 2013 –Respiratory and cardiovascular abnormalities in COPD: the role of exercise, nutritional status and inflammation
Year: 2013


GOLD staging and grading for predicting one-year mortality in COPD patients with severe exacerbation
Source: International Congress 2016 – Biomarkers and phenotypes of COPD
Year: 2016


Evaluation of COPD exacerbations using the EXACT-U
Source: Annual Congress 2010 - COPD exacerbation
Year: 2010


Frequency of COPD exacerbations and severity of COPD
Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations
Year: 2013


Hospital adherence to GOLD guidelines for COPD exacerbation. Results of the European CODP audit
Source: Annual Congress 2013 –Guidelines and exacerbations
Year: 2013


Heterogeneity of group D in the new GOLD classification of COPD
Source: International Congress 2016 – Phenotyping and monitoring airway diseases
Year: 2016


Stability of the exacerbation pattern defined by GOLD 2017 in a real-world COPD population
Source: International Congress 2017 – What is new in COPD diagnosis and classification?
Year: 2017


High risk COPD patients cost less if treated according to GOLD 2011 recommendations
Source: Annual Congress 2013 –COPD diagnosis
Year: 2013


Evaluation of markers for exacerbations of COPD
Source: Eur Respir J 2005; 26: Suppl. 49, 283s
Year: 2005

Methodologies for study of COPD exacerbations
Source: Annual Congress 2012 - ERS COPD exacerbation guidelines: methodologies and overview
Year: 2012

Clinical clustering of COPD patients is useful to predict future COPD exacerbations
Source: International Congress 2018 – New predictors of morbidity and mortality in COPD
Year: 2018

Socioeconomic status shaping GOLD A-D classification in patients with chronic obstructive pulmonary disease
Source: International Congress 2016 – COPD diagnosis and management
Year: 2016

GOLD assessment of COPD patients: Impact of symptoms assessment choice
Source: Annual Congress 2012 - GOLD guidelines 2011: new assessment of COPD
Year: 2012

Modelling exacerbations of COPD
Source: Annual Congress 2012 - Modelling respiratory infections: is it the future or the present?
Year: 2012


Combined COPD assessment using the new GOLD guidelines
Source: Annual Congress 2012 - GOLD guidelines 2011: new assessment of COPD
Year: 2012